Sort by
Refine Your Search
-
on the laboratory’s expertise in conditionally active small molecules, we aim to develop antibacterial compounds that are selectively activated in response to infection. The interested candidate will focus on synthesis
-
of vaccine and therapeutic candidates currently being produced in Good Manufacturing Practice facilities for early phase clinical trials. Minimum Requirements: Education: PhD in Immunology, Data Science and/or
-
project on critical metals from unconventional resources. The project goals are to evaluate the geochemical characteristics of potential feedstocks and develop extraction methods for resources such as rare
-
join a world-renowned institution committed to innovation, collaboration, and excellence in education. You'll have the opportunity to make a meaningful impact on students' academic journeys while working
-
research by visiting https://www.theoliverlab.com/ or searching "Oliver TG" on PubMed. Minimum Requirements: Ph.D. in Cancer Biology, Cell Biology, Molecular Biology, Biochemistry, Genetics, Immunology
-
through excellence in education, research, and clinical practice. With more than 1,500 students, we offer a comprehensive range of programs, including the Master of Nursing (MN), Master of Science in
-
. Through outstanding patient care, groundbreaking research, and exceptional education, we are advancing the future of behavioral health and developmental science. In this role, you will collaborate with
-
, visit: https://sites.duke.edu/yokoyamalab/ Duke is an Equal Opportunity Employer committed to providing employment opportunity without regard to an individual's age, color, disability, gender, gender
-
. Postdoctoral Associate – Translational Microbiome and Critical Care Research The Duke Anesthesiology Microbiome Profiling (AMP) Laboratory (https://anesthesiology.duke.edu/research/serbanescu-lab) under Dr
-
elusive, in part due to our limited understanding of the mechanisms of bnAb induction during natural infection. Dr. Williams has been awarded a NIH UM1 grant to develop new vaccine strategies that can